Analyst Alerts: AIG, Energizer, Arena Pharma, Michael Kors, Lions Gate March 26th
American International Group, Inc. (NYSE:AIG): After meeting with management, Deutsche Bank believes AIG is likely to repurchase more of its own shares and at a faster pace than the market currently expects. The firm thinks $15B-$20B worth of buybacks is achievable over the next two 12 months and maintains a Buy rating on the AIG shares with an increased price target of $40.
Energizer Holdings Inc. (NYSE:ENR): Deutsche Bank lowered its FY12 earnings estimate for Energizer to $5.95 from $6.10, below the company’s guidance of $6.00-$6.10, to reflect battery shelf space losses at Wal-Mart and currency headwinds. However, the firm thinks Energizer’s guidance is still potentially achievable and that the stock is attractively valued at current levels. Deutsche upped its price target for shares to $85 from $80 and maintains a Buy rating.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): Piper Jaffray says Arena Pharmaceuticals shares are rallying ahead of the May 10th FDA Advisory Committee meeting for lorcaserin and that a positive panel vote would likely send the stock significantly higher. Piper finds the risk/reward on shares as compelling and maintains an Overweight rating on Arena.
Michael Kors Holdings (NYSE:KORS): Morgan Stanley raised Michael Kors earnings based on strong comp growth. Shares are Overweight rated.
Lions Gate Entertainment Corp. (NYSE:LGF): Piper Jaffray raised its estimates and price target for Lions Gate after “The Hunger Games” opening weekend came in significantly higher than expected. The firm recommends investors continue to buy the stock.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at email@example.com
To contact the editor responsible for this story: Damien Hoffman at firstname.lastname@example.org